Evaluation of systemic oxidant/antioxidant status and paraoxonase 1 enzyme activities in psoriatic patients treated by narrow band ultraviolet B phototherapy

References

• Emre S, Metin A, Demirseren DD, Kilic S, Isikoglu S, Erel O. The relationship between oxidative stress, smoking and the clinical severity of psoriasis. J Eur Acad Dermatol Venereol 2012 Sep 25. doi: 10.1111/j.1468-3083.2012.04700.x. [Epub ahead of print].
   PubMedGoogle Scholar
• Bickers DR, Athar M. Oxidative stress in the pathogenesis of skin disease. J Invest Dermatol 2006;126:2565–75.
   PubMed Web of Science ®Google Scholar
• Pastore S, Korkina L. Redox imbalance in T cell-mediated skin diseases. Mediators Inflamm 2010;2010:861949.
   PubMed Web of Science ®Google Scholar
• Kilinc Karaarslan I, Girgin Sagin F, Ertam I, Alper S, Ozturk G, Yildirim Sozmen E. Broad-band ultraviolet B phototherapy is associated with elevated serum thiobarbituric acid reactive substance and nitrite-nitrate levels in psoriatic patients. J Eur Acad Dermatol Venereol 2006;20:1226–31.
   PubMed Web of Science ®Google Scholar
• Toker A, Kadi M, Yildirim AK, Aksoy H, Alçay F. Serum lipid profile paraoxonase and arylesterase activities in psoriasis. Cell Biochem Funct 2009;27:176–80.
   PubMed Web of Science ®Google Scholar
• Ramadan R, Tawdy A, Abdel Hay R, Rashed L, Tawfik D. The antioxidant role of paraoxonase 1 and vitamin e in three autoimmune diseases. Skin Pharmacol Physiol 2013;26:2–7.
   PubMed Web of Science ®Google Scholar
• Coimbra S, Oliveira H, Reis F, Belo L, Rocha S, Quintanilha A, et al. Psoriasis therapy and cardiovascular risk factors: a 12-week follow-up study. Am J Clin Dermatol 2010;11:423–32.
   PubMed Web of Science ®Google Scholar
• Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem 2005;38:1103–11.
   PubMed Web of Science ®Google Scholar
• Erel O. A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 2004;37:277–85.
   PubMed Web of Science ®Google Scholar
• Asefi M, Vaisi-Raygani A, Bahrehmand F, Kiani A, Rahimi Z, Nomani H, et al. Paraoxonase 1 (PON1) 55 polymorphism, lipid profiles and psoriasis. Br J Dermatol 2012;167:1279–86.
   PubMed Web of Science ®Google Scholar
• Ferretti G, Bacchetti T, Campanati A, Simonetti O, Liberati G, Offidani A. Correlation between lipoprotein(a) and lipid peroxidation in psoriasis: role of the enzyme paraoxonase-1. Br J Dermatol 2012;166:204–7.
   PubMed Web of Science ®Google Scholar
• Rácz E, Prens EP, Kurek D, Kant M, de Ridder D, Mourits S, et al. Effective treatment of psoriasis with narrow-band UVB phototherapy is linked to suppression of the IFN and Th17 pathways. J Invest Dermatol 2011;131:1547–58.
   PubMed Web of Science ®Google Scholar
• Peus D, Vasa RA, Meves A, Pott M, Beyerle A, Squillace K, et al. H2O2 is an important mediator of UVB-induced EGF-receptor phosphorylation in cultured keratinocytes. J Invest Dermatol 1998;110:966–71.
   PubMed Web of Science ®Google Scholar
• Wang H, Kochevar IE. Involvement of UVB-induced reactive oxygen species in TGF-beta biosynthesis and activation in keratinocytes. Free Radic Biol Med 2005;38:890–7.
   PubMed Web of Science ®Google Scholar
• Murakami M, Taniguchi M, Takama M, Cui JH, Oyanagui Y. UVB-dependent generation of reactive oxygen species by catalase and IgG under UVB light: inhibition by antioxidants and anti-inflammatory drugs. Drug Discov Ther 2008;2:85–93.
   PubMedGoogle Scholar
• Travers JB, Berry D, Yao Y, Yi Q, Konger RL, Travers JB. Ultraviolet B radiation of human skin generates platelet-activating factor receptor agonists. Photochem Photobiol 2010;86:949–54.
   PubMed Web of Science ®Google Scholar
• Fredriksson T, Pettersson U. Severe psoriasis – oral therapy with a new retinoid. Dermatologica 1978;157:238–44.
   PubMedGoogle Scholar
• Fang Y, Hu XH, Jia ZG, Xu MH, Guo ZY, Gao FH. Tiron protects against UVB-induced senescence-like characteristics in human dermal fibroblasts by the inhibition of superoxide anion production and glutathione depletion. Australas J Dermatol 2012;53:172–80.
   PubMed Web of Science ®Google Scholar
• Ridker PM. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 2001;103:1813–8.
   PubMed Web of Science ®Google Scholar
• Coimbra S, Oliveira H, Reis F, Belo L, Rocha S, Quintanilha A, et al. C-reactive protein and leucocyte activation in psoriasis vulgaris according to severity and therapy. J Eur Acad Dermatol Venereol 2010;24:789–96.
   PubMed Web of Science ®Google Scholar
• Yiu KH, Yeung CK, Chan HT, Wong RM, Tam S, Lam KF, et al. Increased arterial stiffness in patients with psoriasis is associated with active systemic inflammation. Br J Dermatol 2011;164:514–20.
   PubMed Web of Science ®Google Scholar
• Romaní J, Caixàs A, Escoté X, Carrascosa JM, Ribera M, Rigla M, et al. Lipopolysaccharide-binding protein is increased in patients with psoriasis with metabolic syndrome, and correlates with C-reactive protein. Clin Exp Dermatol 2013;38:81–4.
   PubMed Web of Science ®Google Scholar
• Vanizor Kural B, Orem A, Cimsit G, Yandi YE, Calapoglu M. Evaluation of the atherogenic tendency of lipids and lipoprotein content and their relationships with oxidant-antioxidant system in patients with psoriasis. Clin Chim Acta 2003;328:71–82.
   PubMed Web of Science ®Google Scholar
• Sergeant A, Makrygeorgou A, Chan WC , Thorrat A, Burden D. C-reactive protein in psoriasis. Br J Dermatol 2008;158:417–9.
   PubMed Web of Science ®Google Scholar
• Laihia JK, Koskinen JO, Waris ME, Jansén CT. Adaptation of the human skin by chronic solar-simulating UV irradiation prevents ultraviolet-B irradiation-induced rise in serum C-reactive protein levels. Photochem Photobiol 2005;81:654–8.
   PubMed Web of Science ®Google Scholar
• Loued S, Isabelle M, Berrougui H, Khalil A. The anti-inflammatory effect of paraoxonase 1 against oxidized lipids depends on its association with high density lipoproteins. Life Sci 2012;90:82–8.
   PubMed Web of Science ®Google Scholar
• Aviram M, Billecke S, Sorenson R, Bisgaier C, Newton R, Rosenblat M, et al. Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities: selective action of human paraoxonase allozymes Q and R. Arterioscler Thromb Vasc Biol 1998;18:1617–24.
   PubMed Web of Science ®Google Scholar